Iterum Therapeutics (ITRMF) Q2 2024 Earnings Report

951 Followers

ITRMF Q2 2024 EPS Results

Actual EPS-$0.23

Consensus EPS-$0.45

Beat/MissBeat by +$0.22

One Year Ago EPS-$0.77

Actual Revenue$0.00

Expected Revenue―

Beat/Miss―

YoY Revenue Growth―

QuarterQ2 2024

Date08/14/2024

TimeBefore Open

Conference CallWednesday, August 14, 2024

ITRMF Upcoming Earnings

Iterum Therapeutics's next earnings date is estimated for November 12, 2026, based on past reporting schedules.

ITRMF Q2 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 12, 2026	2026 (Q3)	- / -	-0.16	―
Aug 07, 2026	2026 (Q2)	- / -	-0.13	―
May 20, 2026	2026 (Q1)	- / -	-0.1	―
Mar 12, 2026	2025 (Q4)	-0.14 / -0.20	-0.12	-66.67% (-0.08)
Nov 14, 2025	2025 (Q3)	-0.09 / -0.16	-0.24	33.33% (+0.08)
Aug 05, 2025	2025 (Q2)	-0.11 / -0.13	-0.23	43.48% (+0.10)
May 13, 2025	2025 (Q1)	-0.14 / -0.10	-0.38	73.68% (+0.28)
Feb 07, 2025	2024 (Q4)	-0.17 / -0.12	-0.81	85.19% (+0.69)
Nov 14, 2024	2024 (Q3)	-0.17 / -0.24	-1.2	80.00% (+0.96)
Aug 14, 2024	2024 (Q2)	-0.45 / -0.23	-0.77	70.13% (+0.54)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed